Nicardipine is another calcium channel blocker, primarily used to treat high blood pressure and certain types of chest pain. Here's the information regarding its use during pregnancy and lactation:
Pregnancy Category C ( by FDA )
Category C (AU TGA )
Animal reproduction studies have shown adverse effects on the fetus, but there are no adequate and well-controlled studies in humans, or animal studies have shown no adverse effects on the fetus, but adequate and well-controlled studies in pregnant women are lacking.
In Australia, the TGA classifies nicardipine as pregnancy category C. Similar to the FDA classification, this means that there may be an increased risk of harm to the fetus based on animal studies, but there are limited human studies available.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.